+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cell Separation Market by End-User and Geography - Forecast and Analysis 2020-2024

  • PDF Icon

    Report

  • 142 Pages
  • November 2019
  • Region: Global
  • TechNavio
  • ID: 4871410
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Global Cell Separation Market: About this market
The cell separation market analysis considers sales from academic institutions and research laboratories, pharmaceutical and biotechnology companies, and hospitals and clinical testing laboratories end-users. Our study also finds the sales of cell separation in Asia, Europe, North America, and ROW. In 2019, the academic institutions and research laboratories segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as demand for cell separation to carry out research studies related to cell enumeration and cell functional assays will play a significant role in the academic institutions and research laboratories segment to maintain its market position. Also, our global cell separation market report looks at factors such as growing adoption of cell separation techniques in research and clinical applications, increasing use of cell separation in cancer research, and high prevalence of HIV/AIDS. However, presence of inconsistent reagents and other ancillary products, exposure risks faced by laboratory personnel, and risk of sample contamination may hamper the growth of the cell separation industry over the forecast period.

Global Cell Separation Market: Overview

Increasing use of cell separation in cancer research
Cell separation helps the identification and characterization of cancer stem cells. The analysis of single cancer cells by medical practitioners can aid in the early diagnosis of tumors, the monitoring of circulating tumor cells, and the evaluation of intratumor heterogeneity. It can also aid the determination of the need for chemotherapeutic treatments. Also, the incidence of cancer is increasing rapidly, especially amongst women. Cervical and breast cancers are the most common types in the world. The rising incidence of cancer is encouraging further research in the field. Moreover, advances in computer techniques, optics, and lasers introduced a new generation of cell separation techniques which are capable of high speed processing of single cell suspensions. This use of cell separation in cancer research will lead to the expansion of the global cell separation market at a CAGR of over 17% during the forecast period.

Growing focus on personalized medicine
The high number of adverse drug reactions, rising awareness about early diagnosis, and advancements in genetic science are driving the growth of personalized medicines. Genome mapping studies are crucial for the development of personalized medicines, and they could only be achieved if cell separation is performed adequately in studies and research projects. The focus on analyzing DNA synthesis is increasing during cell separation, which can be used for the development of personalized medicines against targets. This development is expected to have a positive impact on the overall market growth.

Competitive Landscape
With the presence of a few major players, the global cell separation market is highly concentrated. The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of few leading cell separation manufacturers, that include Akadeum Life Sciences, Becton, Dickinson and Co., Bio-Rad Laboratories Inc., Cell Microsystems Inc., Danaher Corp., General Electric Co., Merck KGaA, Miltenyi Biotec BV & Co. KG, pluriSelect Life Science UG (haftungsbeschränkt) & Co. KG, and Thermo Fisher Scientific Inc.

Also, the cell separation market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

Table of Contents

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
  • Preface
  • Currency conversion rates for US$

PART 03: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING
  • Market definition
  • Market sizing 2019
  • Market outlook
  • Market size and forecast 2019-2024

PART 05: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY END-USER
  • Market segmentation by end-user
  • Comparison by end-user
  • Academic institutions and research laboratories -
  • Market size and forecast 2019-2024
  • Pharmaceutical and biotechnology companies -
  • Market size and forecast 2019-2024
  • Hospitals and clinical testing laboratories -
  • Market size and forecast 2019-2024
  • Market opportunity by end-user

PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS
  • Increasing number of research activities related to stem cells
  • Growing focus on personalized medicine
  • Focus on promotional activities

PART 12: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
  • Competitive scenario

PART 13: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Akadeum Life Sciences
  • Becton, Dickinson and Co.
  • Bio-Rad Laboratories Inc.
  • Cell Microsystems Inc.
  • Danaher Corp.
  • General Electric Co.
  • Merck KGaA
  • Miltenyi Biotec BV & Co. KG
  • pluriSelect Life Science UG (haftungsbeschränkt) & Co. KG
  • Thermo Fisher Scientific Inc.

PART 14: APPENDIX
  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

List of Exhibits
Exhibit 01: Vendor offerings
Exhibit 02: Global healthcare market
Exhibit 03: Segments of global healthcare market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2019
Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
Exhibit 10: Five forces analysis 2019
Exhibit 11: Five forces analysis 2024
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2019
Exhibit 18: End-user - Market share 2019-2024 (%)
Exhibit 19: Comparison by end-user
Exhibit 20: Academic institutions and research laboratories - Market size and forecast 2019-2024 ($ millions)
Exhibit 21: Academic institutions and research laboratories - Year-over-year growth 2020-2024 (%)
Exhibit 22: Pharmaceutical and biotechnology companies - Market size and forecast 2019-2024 ($ millions)
Exhibit 23: Pharmaceutical and biotechnology companies - Year-over-year growth 2020-2024 (%)
Exhibit 24: Hospitals and clinical testing laboratories - Market size and forecast 2019-2024 ($ millions)
Exhibit 25: Hospitals and clinical testing laboratories - Year-over-year growth 2020-2024 (%)
Exhibit 26: Market opportunity by end-user
Exhibit 27: Customer landscape
Exhibit 28: Market share by geography 2019-2024 (%)
Exhibit 29: Geographic comparison
Exhibit 30: North America - Market size and forecast 2019-2024 ($ millions)
Exhibit 31: North America - Year-over-year growth 2020-2024 (%)
Exhibit 32: Europe - Market size and forecast 2019-2024 ($ millions)
Exhibit 33: Europe - Year-over-year growth 2020-2024 (%)
Exhibit 34: Asia - Market size and forecast 2019-2024 ($ millions)
Exhibit 35: Asia - Year-over-year growth 2020-2024 (%)
Exhibit 36: ROW - Market size and forecast 2019-2024 ($ millions)
Exhibit 37: ROW - Year-over-year growth 2020-2024 (%)
Exhibit 38: Key leading countries
Exhibit 39: Market opportunity
Exhibit 40: Impact of drivers and challenges
Exhibit 41: Vendor landscape
Exhibit 42: Landscape disruption
Exhibit 43: Vendors covered
Exhibit 44: Vendor classification
Exhibit 45: Market positioning of vendors
Exhibit 46: Akadeum Life Sciences - Vendor overview
Exhibit 47: Akadeum Life Sciences - Product segments
Exhibit 48: Akadeum Life Sciences - Organizational developments
Exhibit 49: Akadeum Life Sciences - Key offerings
Exhibit 50: Becton, Dickinson and Co. - Vendor overview
Exhibit 51: Becton, Dickinson and Co. - Business segments
Exhibit 52: Becton, Dickinson and Co. - Organizational developments
Exhibit 53: Becton, Dickinson and Co. - Geographic focus
Exhibit 54: Becton, Dickinson and Co. - Segment focus
Exhibit 55: Becton, Dickinson and Co. - Key offerings
Exhibit 56: Bio-Rad Laboratories Inc. - Vendor overview
Exhibit 57: Bio-Rad Laboratories Inc. - Business segments
Exhibit 58: Bio-Rad Laboratories Inc. - Organizational developments
Exhibit 59: Bio-Rad Laboratories Inc. - Geographic focus
Exhibit 60: Bio-Rad Laboratories Inc. - Segment focus
Exhibit 61: Bio-Rad Laboratories Inc. - Key offerings
Exhibit 62: Cell Microsystems Inc. - Vendor overview
Exhibit 63: Cell Microsystems Inc. - Product segments
Exhibit 64: Cell Microsystems Inc. - Organizational developments
Exhibit 65: Cell Microsystems Inc. - Key offerings
Exhibit 66: Danaher Corp. - Vendor overview
Exhibit 67: Danaher Corp. - Business segments
Exhibit 68: Danaher Corp. - Organizational developments
Exhibit 69: Danaher Corp. - Geographic focus
Exhibit 70: Danaher Corp. - Segment focus
Exhibit 71: Danaher Corp. - Key offerings
Exhibit 72: General Electric Co. - Vendor overview
Exhibit 73: General Electric Co. - Business segments
Exhibit 74: General Electric Co. - Organizational developments
Exhibit 75: General Electric Co. - Geographic focus
Exhibit 76: General Electric Co. - Segment focus
Exhibit 77: General Electric Co. - Key offerings
Exhibit 78: Merck KGaA - Vendor overview
Exhibit 79: Merck KGaA - Business segments
Exhibit 80: Merck KGaA - Organizational developments
Exhibit 81: Merck KGaA - Geographic focus
Exhibit 82: Merck KGaA - Segment focus
Exhibit 83: Merck KGaA - Key offerings
Exhibit 84: Miltenyi Biotec BV & Co. KG - Vendor overview
Exhibit 85: Miltenyi Biotec BV & Co. KG - Product segments
Exhibit 86: Miltenyi Biotec BV & Co. KG - Organizational developments
Exhibit 87: Miltenyi Biotec BV & Co. KG - Key offerings
Exhibit 88: pluriSelect Life Science UG (haftungsbeschränkt) & Co. KG - Vendor overview
Exhibit 89: pluriSelect Life Science UG (haftungsbeschränkt) & Co. KG - Product segments
Exhibit 90: pluriSelect Life Science UG (haftungsbeschränkt) & Co. KG - Key offerings
Exhibit 91: Thermo Fisher Scientific Inc. - Vendor overview
Exhibit 92: Thermo Fisher Scientific Inc. - Business segments
Exhibit 93: Thermo Fisher Scientific Inc. - Organizational developments
Exhibit 94: Thermo Fisher Scientific Inc. - Geographic focus
Exhibit 95: Thermo Fisher Scientific Inc. - Segment focus
Exhibit 96: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 97: Validation techniques employed for market sizing
Exhibit 98: Definition of market positioning of vendors

Executive Summary

The following companies as the key players in the global cell separation market: Akadeum Life Sciences, Becton, Dickinson and Co., Bio-Rad Laboratories Inc., Cell Microsystems Inc., Danaher Corp., General Electric Co., Merck KGaA, Miltenyi Biotec BV & Co. KG, pluriSelect Life Science UG (haftungsbeschränkt) & Co. KG, and Thermo Fisher Scientific Inc.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the growing focus on personalized medicine.”

According to the report, one of the major drivers for this market is the increasing use of cell separation in cancer research.

Further, the report states that one of the major factors hindering the growth of this market is the presence of inconsistent reagents.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Akadeum Life Sciences
  • Becton
  • Dickinson Co.
  • Bio-Rad Laboratories Inc.
  • Cell Microsystems Inc.
  • Danaher Corp.
  • General Electric Co.
  • Merck KGaA
  • Miltenyi Biotec BV & Co. KG
  • pluriSelect Life Science UG (haftungsbeschränkt) & Co. KG
  • Thermo F